Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 40,219 Reduced 5.1% |
$816,044
$20.29 p/Share
|
Nov 02
2020 |
BBIO
|
Michael Thomas Henderson
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.6% |
$386,300
$38.63 p/Share
|
Nov 02
2020 |
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.57% |
$29,580
$9.86 p/Share
|
Nov 02
2020 |
FORR
|
David Boyce |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 21.6% |
$75,500
$37.75 p/Share
|
Nov 02
2020 |
FORR
|
Steven P. Peltzman
CBTO |
SELL
Open market or private sale
|
Direct | 2,710 Reduced 15.09% |
$103,414
$38.16 p/Share
|
Nov 02
2020 |
CCF
|
Adam Chase
President/CEO |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.63% |
$121,625
$97.3 p/Share
|
Nov 02
2020 |
CDLX
|
Scott D. Grimes
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.61% |
$151,420
$75.71 p/Share
|
Nov 02
2020 |
SWBI
|
Michael F Golden
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.52% |
$174,000
$17.4 p/Share
|
Nov 02
2020 |
JOUT
|
Thomas F Pyle Jr
Director |
SELL
Open market or private sale
|
Direct | 2,981 Reduced 5.61% |
$259,735
$87.13 p/Share
|
Nov 02
2020 |
YEXT
|
Steven Cakebread
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 25.93% |
$164,000
$16.4 p/Share
|
Nov 02
2020 |
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 91 Reduced 0.43% |
$3,364
$36.97 p/Share
|
Nov 02
2020 |
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 159 Reduced 0.5% |
$5,878
$36.97 p/Share
|
Nov 02
2020 |
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 142 Reduced 0.45% |
$5,250
$36.97 p/Share
|
Nov 02
2020 |
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 116 Reduced 0.46% |
$4,289
$36.97 p/Share
|
Nov 02
2020 |
NTGR
|
Tamesa Rogers
Chief People Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 6.71% |
$94,680
$31.56 p/Share
|
Nov 02
2020 |
DGICA
|
Dennis Joseph Bixenman
Director |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 67.97% |
$169,680
$14.14 p/Share
|
Nov 02
2020 |
RAPT
|
Dirk G. Brockstedt
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 1,910 Reduced 15.7% |
$53,595
$28.06 p/Share
|
Nov 02
2020 |
RAPT
|
Karen C Lam
VP, Finance and Controller |
SELL
Open market or private sale
|
Direct | 2,022 Reduced 13.7% |
$56,899
$28.14 p/Share
|
Nov 02
2020 |
RAPT
|
William Ho
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.54% |
$28,060
$28.06 p/Share
|
Nov 02
2020 |
RLMD
|
Charles J Casamento
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 5.75% |
$90,870
$30.29 p/Share
|
Nov 02
2020 |
SRLP
|
Paul A. Scoff
Officer |
SELL
Open market or private sale
|
Direct | 1,702 Reduced 10.17% |
$27,436
$16.12 p/Share
|
Nov 02
2020 |
TCX
|
Elliot Noss
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.91% |
$371,450
$74.29 p/Share
|
Nov 02
2020 |
CPSI
|
David A Dye
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.33% |
$27,800
$27.8 p/Share
|
Nov 02
2020 |
CPSI
|
John B Douglas Jr |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.42% |
$27,820
$27.82 p/Share
|
Nov 02
2020 |
ARCT
|
Pad Chivukula
Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.4% |
$552,800
$55.28 p/Share
|
Nov 02
2020 |
QUOT
|
Mc Kenna Michelle
Director |
SELL
Open market or private sale
|
Direct | 2,216 Reduced 4.18% |
$19,811
$8.94 p/Share
|
Nov 02
2020 |
PHAT
|
Azmi Nabulsi
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 14,500 Reduced 1.67% |
$534,035
$36.83 p/Share
|
Nov 02
2020 |
EBMT
|
Kenneth M Walsh
Director |
SELL
Open market or private sale
|
Direct | 1,212 Reduced 0.48% |
$23,767
$19.61 p/Share
|
Nov 02
2020 |
PBYI
|
Richard Paul Bryce
Officer |
SELL
Open market or private sale
|
Direct | 97 Reduced 0.13% |
$758
$7.81 p/Share
|
Nov 02
2020 |
PBYI
|
Alan H Auerbach
President and CEO |
SELL
Open market or private sale
|
Direct | 371 Reduced 0.01% |
$2,901
$7.82 p/Share
|
Nov 02
2020 |
BDTX
|
David M. Epstein |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 1.66% |
$378,000
$31.5 p/Share
|
Nov 02
2020 |
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 15,714 Reduced 4.42% |
$330,780
$21.05 p/Share
|
Nov 02
2020 |
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$17,200
$0.86 p/Share
|
Nov 02
2020 |
ONCS
|
Daniel J. O'Connor
CEO and President |
SELL
Open market or private sale
|
Direct | 3,280 Reduced 3.1% |
$12,431
$3.79 p/Share
|
Nov 02
2020 |
BCDA
|
Eric Duckers
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 8,435 Reduced 41.1% |
$16,954
$2.01 p/Share
|
Nov 02
2020 |
EPAY
|
Nigel K Savory
Managing Director Europe |
SELL
Open market or private sale
|
Direct | 1,416 Reduced 0.88% |
$56,116
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
John Francis Kelly
GM, Legal Solutions |
SELL
Open market or private sale
|
Direct | 413 Reduced 0.67% |
$16,367
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
Norman J Deluca
MD of Banking Solutions |
SELL
Open market or private sale
|
Direct | 854 Reduced 0.91% |
$33,844
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
Robert A Eberle
President & CEO |
SELL
Open market or private sale
|
Direct | 2,557 Reduced 0.57% |
$101,334
$39.63 p/Share
|
Nov 02
2020 |
EPAY
|
Richard Douglas Booth
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 975 Reduced 0.89% |
$38,639
$39.63 p/Share
|
Nov 02
2020 |
DRNA
|
Bob D Brown
Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct | 8,185 Reduced 23.59% |
$172,131
$21.03 p/Share
|
Nov 02
2020 |
DRNA
|
James B Weissman
Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct | 4,360 Reduced 12.04% |
$91,342
$20.95 p/Share
|
Nov 02
2020 |
EIDX
|
Cameron Turtle
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 16.02% |
$891,500
$71.32 p/Share
|
Nov 02
2020 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 5,277 Reduced 0.02% |
$1,055
$0.2 p/Share
|
Nov 02
2020 |
NEM
|
Robert D Atkinson
EVP & COO |
SELL
Open market or private sale
|
Direct | 1,347 Reduced 1.53% |
$85,198
$63.25 p/Share
|
Nov 02
2020 |
NEM
|
Thomas Ronald Palmer
President & CEO |
SELL
Open market or private sale
|
Direct | 5,150 Reduced 2.0% |
$325,738
$63.25 p/Share
|
Nov 02
2020 |
NEM
|
John Kitlen
VP, Controller & CAO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.3% |
$126,500
$63.25 p/Share
|
Nov 02
2020 |
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,012,350
$67.49 p/Share
|
Nov 02
2020 |
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.57% |
$680,200
$68.02 p/Share
|
Nov 02
2020 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 8,893 Reduced 0.1% |
$604,902
$68.02 p/Share
|
Nov 02
2020 |